Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3
Closed -$295 1447
2025
Q2
$295 Sell
3
-3
-50% -$284 ﹤0.01% 1391
2025
Q1
$556 Hold
6
﹤0.01% 1338
2024
Q4
$545 Buy
+6
New +$551 ﹤0.01% 1330

Other funds holding AMED

WPG Advisers's AMED Position: Q3 2025 in Review

WPG Advisers sold out of Amedisys (AMED) in Q3 2025, closing a stake of 3 shares — an estimated $295 sold.

WPG Advisers first reported a position in AMED in Q4 2024 and held it in 3 quarters. The position peaked at $556 in Q1 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • WPG Advisers reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • WPG Advisers sold 3 Amedisys shares in Q3 2025, an estimated $295.
  • WPG Advisers first reported a position in Amedisys in Q4 2024 and held it in 3 quarters.
  • WPG Advisers's Amedisys position peaked at $556 in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on WPG Advisers's 13F filing for Q3 2025, filed 29 Oct 2025.